U07.1
Conditions
Interventions
Group 1: Patient with proven SARS COV2 infection are interviewed once about their course of disease and their perception of the disease.
Sponsors
Ruprecht-Karls-Universität Heidelberg
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients with confirmed SARS-CoV-2 infection by PCR (or rapid test when available) diagnosis from nasopharynx, oropharynx, stool, or blood at the completion of their isolation period OR first degree relatives of these patients (in case of patient death)
Exclusion criteria
Exclusion criteria: • No consent • No ability to communicate in a language adequate for the patient
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Investigate the course of illness and assess potential risk factors for a complicated course and associated timing 2. Understand the rapidity of diagnosis from onset of symptoms 3. Investigate perspectives of patients with COVID-19 on their disease and their ability to isolate | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Assess clinical and sociodemographic characteristics of patients with COVID-19 2. Monitoring different trends over time (symptoms, incidence) 3. Assessment of regional differences in management and clinical outcome 4. Assessment of the temporal relationship between the severity of SARS-CoV-2 infection and death 5. To assess the economic burden of disease to the patient 6. Estimate of direct health care costs based on length of stay, time on ICU, time with mechanical ventilation 7. Assess the ability to comply with isolation methods 8. Understand the sequence and reversibility of symptoms (descriptive) to informs screening algorithms | — |
Countries
Germany
Contacts
Public ContactClaudia Denkinger
Sektion Klinische Tropenmedizin, Universita¨tsklinikum Heidelberg
Outcome results
None listed